Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6801–6850 of 18650
he will be resigning as Chief Financial Officer (“CFO”) of the Company, effective as of February 2, 2024.
On January 24, 2024, the Board of Directors (the “Board”) of CPI Card Group Inc. (the “Company”) appointed John Lowe, who currently serves as Executive Vice President, End-to-End Payment Solutions, as President and Chief Executive Officer of the Company, effective January 25, 2024.
Mr. Scheirman will end his service as President and Chief Executive Officer on January 25, 2024
At that time, Jeffery T. Mezger, KB Home’s president and chief executive officer since 2006 and chairman since 2016, will become chairman and chief executive officer.
On January 21, 2024, the Board of Directors (“Board”) of Inogen, Inc. (the “Company”) appointed Michael Bourque to serve as Executive Vice President, Chief Financial Officer and Treasurer (“CFO”) of the Company, effective March 4, 2024.
· Chandan Basho, previously Chief Financial Officer and Chief Strategy Officer, was appointed Chief Financial Officer and Chief Operating Officer.
· Brandon Sim, previously Co-Chief Executive Officer, was appointed Chief Executive Officer and President;
In connection with the re-appointment of Mr. Curelaru as the Company’s Chief Financial Officer, Mr. Brock resigned as Interim Chief Financial Officer of the Company, on and effective January 22, 2024.
On January 22, 2024, Mr. Curelaru was re-appointed as the Company’s Chief Financial Officer of the Company, effective immediately.
On January 19, 2024, Ellen Harrison notified the board of directors (the “Board”) of MedMen Enterprises Inc. (the “Company”) of her resignation from her positions as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
On January 18, 2024, Colony Bankcorp, Inc. (the “Company”), named Mr. Derek Shelnutt, the current Chief Accounting Officer of the Company and Chief Financial Officer of Colony Bank (the “Bank”), as Executive Vice President and Chief Financial Officer of the Company effective January 23, 2024.
On January 23, 2024, the Company issued a press release announcing the retirement of Mr. Jordan and the appointment of Mr. Rivera
On January 23, 2024, the Company announced it would appoint Eric Rivera, currently the Company’s vice president, chief accounting officer and corporate controller, to the role of interim chief financial officer of the Company, effective February 23, 2024 upon Mr. Jordan’s retirement.
the Board of Directors of Duluth Holdings Inc. (the “Company”) appointed Heena Agrawal as Senior Vice President and Chief Financial Officer of the Company, effective February 12, 2024.
Effective February 12, 2024, Mr. Murphy will step down from his role as Interim Chief Financial Officer and will continue in his role as VP, Chief Accounting Officer and will assume responsibility for the Company’s treasury function
The Company has also announced that Brian Markison, the Chairman of the Board, has been appointed Executive Chairman as of January 23, 2024 to serve in that role until the Effective Date and will become the Company’s Chief Executive Officer effective on the Effective Date.
Mary Anne Heino, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), notified the Board on January 18, 2024, of her intention to retire as Chief Executive Officer, effective March 1, 2024
On January 23, 2024, the Company announced that the Board appointed Thomas L. Monahan III to serve as the Chief Executive Officer of the Company and, following the recommendation of the Nominating and Board Governance Committee of the Board, appointed Mr. Monahan to serve as a member of the Board, each effective as of the Transition Date.
On January 23, 2024, Krishnan Rajagopalan, the President and Chief Executive Officer of the Company, notified the Board of Directors (the “Board”) of the Company of his decision to step down as the Company’s President and Chief Executive Officer on March 4, 2024 (the “Transition Date”) and retire from the Company on April 1, 2024.
On January 17, 2024, View, Inc. (the “Company”) was informed by Amy Reeves, the Company’s Chief Financial Officer, that she will resign from such position effective February 2, 2024.
Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
Pursuant to the Settlement Agreement, the parties confirmed Mr. Haas’s resignation as Chief Financial Officer, effective January 18, 2024.
On January 22, 2024, Thomas W. Ohrt was appointed the Company’s Chief Financial Officer.
Judith S. Miller resigned as the Company’s Interim Chief Executive Officer and was appointed as a member of the Company’s Board of Directors (the “ Board ”), as the Chief Business Officer of the Company, and as the Interim Chief Financial Officer of the Company
Chad Pawlak was appointed as Chief Executive Officer of Genvor Incorporated
Ms. Austin will retain her positions as Chief Executive Officer of the Bank and as President and Chief Executive Officer of the Company until her retirement at year-end 2024.
mutually agreed that Mr. Kalamaras would depart effective as of January 22, 2024
promoted Jason Vlacich, the Chief Accounting Officer of the Company, to the role of Chief Financial Officer and Chief Accounting Officer, effective as of January 23, 2024
Gregory R. Adelson will be appointed Chief Executive Officer and President of the Company, effective July 1, 2024.
The Amendment amended the Employment Agreement to reflect, among other things, the following changes: a) In Section 1.1, of the Employment Agreement, reference to Employee’s role as President was stricken.
On January 22, 2024, SIGA Technologies, Inc. (the “Company”) announced the appointment of Diem Nguyen, Ph.D., MBA, as Chief Executive Officer of the Company and a member of the Company’s Board of Directors, in each case, effective as of January 27, 2024
the Board appointed Scott A. Kingsley President and Chief Executive Officer of the Company, effective May 21, 2024.
the Board approved the promotion of Annette L. Burns to Chief Financial Officer of the Company, effective May 21, 2024.
The appointment follows the decision of the Board on January 19, 2024 to place Vikram Luthar, the Company’s Chief Financial Officer and Senior Vice President, on administrative leave, effective immediately.
On January 21, 2024, Archer-Daniels-Midland Company (the “Company”) announced that the Board of Directors of the Company (the “Board”) has appointed Ismael Roig to serve as the Company’s Interim Chief Financial Officer.
On January 21, 2024 (the “ Effective Date ”), Edmond Thomas retired from his position as President and Chief Executive Officer of Tilly’s, Inc. (the “ Company ”) and as a director of the board of directors (the “ Board ”) of the Company.
On the Effective Date, the Board appointed Hezy Shaked, the Company’s co-founder, Chief Strategy Officer and Executive Chairman of the Board as the Company’s interim President and Chief Executive Officer, to serve in such capacities until his successor is duly elected and qualified or until his earlier death, resignation or removal.
On January 20, 2024, the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) appointed Dale Curtis Hogue, Jr. as Interim Chief Executive Officer of the Company, effective January 20, 2024.
On January 16, 2024, in connection with the Workforce Reduction, the Company terminated Mr. W. Anderson’s employment with the Company, effective as of January 16, 2024
On January 16, 2024, the Board of Directors (the “Board”) of Energy Recovery, Inc. (the “Company”) appointed Mr. David Moon, age 61, as President and Chief Executive Officer effective immediately.
Concurrent with Ms. Sullivan’s promotion, Ann Joyce, the Company’s Interim Chief Executive Officer, will serve as an executive consultant for the Company through February 29, 2024, at which time she will no longer be employed by the Company.
the Company announced that it had promoted Amy A. Sullivan to the position of Chief Executive Officer to be effective February 4, 2024.
On January 18, 2024, the Board of the Company elected Mark E. Zalatoris to serve as the Company’s President and Chief Executive Officer effective February 1, 2024 and elected Mr. Zalatoris to fill the vacancy resulting from Mr. Sabshon’s resignation as a director also effective February 1, 2024.
On January 13, 2024, Mitchell A. Sabshon, the President and Chief Executive Officer of the Company notified the Company that, because of his decision to retire from his position with Inland Investments, an affiliate of the Company’s Business Manager, he was also resigning his position as a director of the Company and as the Company’s President and Chief Executive Officer, effective at the close of business on January 31, 2024.
appointed Benjamin G. Wolff as President and Chief Executive Officer of the Company, effective February 23, 2024
the Company has appointed Ewout L. Steenbergen as its Executive Vice President and Chief Financial Officer effective as of March 15, 2024.
Upon Mr. Steenbergen's commencement of employment, David I. Goulden will no longer serve as the Company's Chief Financial Officer.
Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.
On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.